Evolutionary Genomics Stock Technical Analysis

FNAM Stock  USD 0.0002  0.00  0.00%   
Evolutionary Genomics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Evolutionary Genomics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Evolutionary, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Evolutionary
  
Evolutionary Genomics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Please note, there is a significant difference between Evolutionary Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolutionary Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Evolutionary Genomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Evolutionary Genomics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evolutionary Genomics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evolutionary Genomics.
0.00
11/10/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/08/2026
0.00
If you would invest  0.00  in Evolutionary Genomics on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Evolutionary Genomics or generate 0.0% return on investment in Evolutionary Genomics over 90 days. Evolutionary Genomics is related to or competes with Doseology Sciences, Sigyn Therapeutics, LFTD Partners, and Healthlynked Corp. Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively se... More

Evolutionary Genomics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evolutionary Genomics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evolutionary Genomics upside and downside potential and time the market with a certain degree of confidence.

Evolutionary Genomics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Evolutionary Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evolutionary Genomics' standard deviation. In reality, there are many statistical measures that can use Evolutionary Genomics historical prices to predict the future Evolutionary Genomics' volatility.
Hype
Prediction
LowEstimatedHigh
0.000.00020.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00020.00
Details
Naive
Forecast
LowNextHigh
0.00020.00020.0002
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00020.00020.0002
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evolutionary Genomics. Your research has to be compared to or analyzed against Evolutionary Genomics' peers to derive any actionable benefits. When done correctly, Evolutionary Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evolutionary Genomics.

Evolutionary Genomics Backtested Returns

We have found three technical indicators for Evolutionary Genomics, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Evolutionary Genomics are completely uncorrelated.

Auto-correlation

    
  1.00  

Perfect predictability

Evolutionary Genomics has perfect predictability. Overlapping area represents the amount of predictability between Evolutionary Genomics time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evolutionary Genomics price movement. The serial correlation of 1.0 indicates that 100.0% of current Evolutionary Genomics price fluctuation can be explain by its past prices.
Correlation Coefficient1.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0
Evolutionary Genomics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Evolutionary Genomics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Evolutionary Genomics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Evolutionary Genomics Technical Analysis

Indicator
Time Period
Execute Indicator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Evolutionary Genomics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Evolutionary Genomics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Evolutionary Genomics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Evolutionary Genomics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Evolutionary Genomics price pattern first instead of the macroeconomic environment surrounding Evolutionary Genomics. By analyzing Evolutionary Genomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Evolutionary Genomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Evolutionary Genomics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Evolutionary Genomics February 8, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Evolutionary stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Other Information on Investing in Evolutionary Pink Sheet

Evolutionary Genomics financial ratios help investors to determine whether Evolutionary Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evolutionary with respect to the benefits of owning Evolutionary Genomics security.